MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PTGX made $46,016K in revenue. -$130,149K in net income. Net profit margin of -282.83%.

Income Overview

Revenue
$46,016K
Net Income
-$130,149K
Net Profit Margin
-282.83%
EPS
-$2.05
Unit: Thousand (K) dollars

Income Statement
2025-12-31
License and collaboration revenue
46,016
Research and development
159,290
General and administrative
44,853
Total operating expenses
204,143
(loss) income from operations
-158,127
Interest income
28,789
Other income (expense), net
27
(loss) income before income tax expense
-129,311
Provision for income taxes
838
Net (loss) income
-130,149
Basic EPS
-2.05
Diluted EPS
-2.05
Basic Average Shares
63,573,048
Diluted Average Shares
63,573,048
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$130,149K (loss) income beforeincome tax expense-$129,311K Provision for income taxes$838K Interest income$28,789K Other income(expense), net$27K (loss) income fromoperations-$158,127K License andcollaboration revenue$46,016K Total operatingexpenses$204,143K Research and development$159,290K General andadministrative$44,853K

Protagonist Therapeutics, Inc (PTGX)

Protagonist Therapeutics, Inc (PTGX)